Oncimmune
Operates as a cancer detection company. The Company focuses on the development of autoantibody assay technologies that allow cancer detection earlier than other methods. Learn more
Launch date
Employees
Market cap
CAD28.2m
Enterprise valuation
CAD36m (Public information from Sep 2024)
Share price
£0.17665 ONC.L
Company register number 04606727
Leeds England (HQ)
Authorizing premium user...